GEVONasdaqIndustrial Organic ChemicalsFiscal year ends December 31
Gevo, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.13−0.04 (-3.42%)
Close on Oct 19, 2026
- Market cap
- $267.87M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.34 (−54.25%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Gevo, Inc. grew revenue 121.4% to $177.51M over the twelve months to Jun 30, 2026. Free cash flow was -$56.65M.
Revenue
$177.51M
+121.4% vs. a year earlier
Operating income
-$182.47M
TTM Q2 2026
Free cash flow
-$56.65M
TTM Q2 2026
EPS, diluted
-$0.90
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $267.87M
- P/E ratio
- –
- Price to sales
- 1.51
- Price to book
- 0.98
- Dividend yield
- –
- Free cash flow yield
- -21.15%
Fundamentals
- Revenue
- $177.51M
- Net income
- -$212.89M
- EPS, diluted
- -$0.90
- Free cash flow
- -$56.65M
- Book value per share
- $1.15
- Diluted shares
- 237M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$177.51M+121.4% YoY
Gross profit
$84.04M+197.3% YoY
Operating income
-$182.47M
Net income
-$212.89M
EPS, diluted
-$0.90
Free cash flow
-$56.65M
Reported periodTrailing twelve months